GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma

被引:6
|
作者
Canpolat, Tuba [1 ]
Ersoz, Canan [1 ]
Uguz, Aysun [1 ]
Vardar, Mehmet Ali [2 ]
Altintas, Aytekin [2 ]
机构
[1] Cukurova Univ, Sch Med, Dept Pathol, Adana, Turkey
[2] Cukurova Univ, Sch Med, Dept Obstet & Gynecol, Adana, Turkey
关键词
GLUT-1; Prognosis; Endometrial hyperplasia; Endometrioid adenocarcinoma;
D O I
10.5146/tjpath.2015.01352
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: Malignant cells show increased glucose uptake in in vitro and in vivo studies. This uptake is mediated by glucose transporter proteins. GLUT-1 is the most common transporter protein, and its expression is reported to be increase in many human cancers. The aim of this study is to determine the GLUT-1 overexpression in benign, hyperplastic, and malignant endometrial tissues, to evaluate the usefulness of GLUT-1 expression in endometrial hyperplasia, and to determine its role in the neoplastic progression to endometrioid type adenocarcinoma. We also aimed to analyze prognostic clinical parameters, predict prognosis, and survival. Material and Method: We examined immunohistochemical expression of GLUT-1 in 91 cases of endometrial hyperplasia, 100 cases of endometrioid type adenocarcinoma, and 10 proliferative endometrial tissues. The percentage of positive cells and staining intensity were assessed in a semi quantitative fashion and scored (1+ to 3+). Results: GLUT-1 immunoreactivity was not present in proliferative endometrium. Twenty-nine (31.9%) of 91 endometrial hyperplasia cases showed positive immunoreactivity, of which only six were cases of hyperplasia without atypia while 23 of them were cases with atypia. We found GLUT-1 positivity of 95% in endometrioid type adenocarcinoma. GLUT-1 overexpression was not significantly correlated with any of the clinicopathological parameters except histological grade in endometrioid adenocarcinoma; the survival was not found to be correlated with GLUT-1 expression. Conclusion: GLUT-1 immunostaining may be useful in distinguishing hyperplasia without atypia from hyperplasia with atypia; GLUT-1 overexpression is a consistent feature of endometrioid adenocarcinoma. A correlation between GLUT-1 expression and tumor grade has been found, although other prognostic parameters and survival has no meaningful correlation.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [11] HIF-1 alpha and GLUT-1 Expression in Atypical Endometrial Hyperplasia, Type I and II Endometrial Carcinoma: A Potential Role in Pathogenesis
    Al-Sharaky, Dalia Rifaat
    Abdou, Asmaa Gaber
    Wahed, Moshira Mohammed Abdel
    Kassem, Hend Abdou
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (05) : EC20 - EC27
  • [12] Expression of GLUT-1 in psoriasis and the relationship between GLUT-1 upregulation induced by hypoxia and proliferation of keratinocyte growth
    Tao, Juan
    Yang, Jing
    Wang, Lin
    Li, Yan
    Liu, Ye-Qjang
    Dong, Jing
    Li, Li
    Wen, Xue
    Shen, Guan-Xin
    Tu, Ya-Ting
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 51 (03) : 203 - 207
  • [13] The expression of cyclooxygenase-1 and-2 in proliferative endometrium and endometrial adenocarcinoma
    Uotila, PJ
    Erkkola, RU
    ANNALS OF MEDICINE, 2002, 34 (06) : 428 - 433
  • [14] Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma
    Felix Berlth
    Stefan Mönig
    Berit Pinther
    Peter Grimminger
    Martin Maus
    Hans Schlösser
    Patrick Plum
    Ute Warnecke-Eberz
    Olivier Harismendy
    Uta Drebber
    Elfriede Bollschweiler
    Arnulf Hölscher
    Hakan Alakus
    Annals of Surgical Oncology, 2015, 22 : 822 - 831
  • [15] GLUT-1 and GLUT-14 as independent prognostic factors in gastric adenocarcinoma.
    Berlth, Felix
    Grimminger, Peter Philipp
    Maus, Martin Karl Herbert
    Pinther, Berit
    Plum, Patrick
    Schloesser, Hans Anton
    Drebber, Uta
    Bollschweiler, Elfriede
    Hoelscher, Arnulf Heinrich
    Moenig, Stefan Paul
    Alakus, Hakan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [16] Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma
    Berlth, Felix
    Moenig, Stefan
    Pinther, Berit
    Grimminger, Peter
    Maus, Martin
    Schloesser, Hans
    Plum, Patrick
    Warnecke-Eberz, Ute
    Harismendy, Olivier
    Drebber, Uta
    Bollschweiler, Elfriede
    Hoelscher, Arnulf
    Alakus, Hakan
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S822 - S831
  • [17] GLUT-1 Expression in Breast Cancer
    Okcu, Oguzhan
    Sen, Bayram
    Ozturk, Cigdem
    Guvendi, Gulname Findik
    Bedir, Recep
    TURKISH JOURNAL OF PATHOLOGY, 2022, 38 (02) : 114 - 121
  • [18] P-mTOR and Glut-1: Metabolically targeted biomarkers in endometrial carcinoma
    Daudi, S.
    Wahl, H.
    Kirschkigar, M.
    Vandeven, N.
    Rhode, J.
    Griffith, K.
    Liu, J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S72 - S72
  • [19] Expression of glucose transporter 1 (GLUT-1) in human endometrial tissue, peritoneal endometriotic lesions and deep infiltrating endometriosis
    von Kleinsorgen, C.
    Wilson, T.
    Thiel-Moder, U.
    Ebert, A. D.
    Reinfandt, M.
    Papadopolous, T.
    HUMAN REPRODUCTION, 2010, 25 : I212 - I213
  • [20] Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression
    Heilig, CW
    Kreisberg, JI
    Freytag, S
    Murakami, T
    Ebina, Y
    Guo, L
    Heilig, K
    Loberg, R
    Qu, X
    Jin, Y
    Henry, D
    Brosius, FC
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (04) : F657 - F666